AGIOS PHARMACEUTICALS, INC. (AGIO) › Operating IncomeAGIOS PHARMACEUTICALS, INC. (AGIO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$16.63M2012: -$23.00M2013: -$38.88M2014: -$54.13M2015: -$118.70M2016: -$200.99M2017: -$320.79M2018: -$362.48M2019: -$316.27M2020: -$335.92M2021: -$378.42M2022: -$389.05M2023: -$391.49M2024: -$425.74M2025: -$472.13M-$472.13M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$472.13M-10.9%2024-$425.74M-8.7%2023-$391.49M-0.6%2022-$389.05M-2.8%2021-$378.42M-12.7%2020-$335.92M-6.2%2019-$316.27M+12.7%2018-$362.48M-13.0%2017-$320.79M-59.6%2016-$200.99M-69.3%2015-$118.70M-119.3%2014-$54.13M-39.2%2013-$38.88M-69.1%2012-$23.00M-38.3%2011-$16.63M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share